Fibrodysplasia Ossificans Progressiva: Difference between revisions

No edit summary
No edit summary
Line 68: Line 68:
== Medical Management (current best evidence)  ==
== Medical Management (current best evidence)  ==


add text here
''Medications ''
 
*Reduces the pain and severity of flare-ups
 
 
 
''Surgical release of joint contractures''
 
*Usually unsuccessful
 
 
 
''Osteotomy of heterotropic bone''
 
*Mobilizes joints
*Usually counterproductive because new heterotrophic ossificans can form at the site
 
 
 
''Repositioned surgically''
 
*Improves the patients overall functional status
*Rare
 
 
 
<u>'''Ultimately, there is not much that can be done to cure this disease.'''</u><br><br>


== Physical Therapy Management (current best evidence)  ==
== Physical Therapy Management (current best evidence)  ==

Revision as of 23:21, 21 March 2016

 

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Definition/Description[edit | edit source]

Fibrodysplasia Ossificans Progressiva is a rare, genetic disorder than transforms ligaments, muscles and tendons into bone outside the skeleton that impairs movement.

Prevalence[edit | edit source]

  • 1 in every 2 million people are diagnosed with Fibrodysplasia Ossificans Porgressiva
  • Nearly 90% of the time it is misdiagnosed and mismanaged. (Lakkrieddy)
  • 67% undergo invasive procedures for diagnosis and treatment
  • More than 50% end up with lifelong disabilities
  • Mostly occurs in children

Characteristics/Clinical Presentation
[edit | edit source]

  • Hearing impairments in approximately 50% of patients
  • Pneumonia and right sided heart failure
  • Controversial malformations
  • Ossification of intercostal muscles
  • Kyphoscoliosis and lordosis
  • Severe weight loss
  • Torticollis
  • TMJ complications

Medications[edit | edit source]

For acute flare-ups:

  • short term high does corticosteroids
  • NSAIDS
  • Biophosphonates


  • Radiotherapy 

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

Blood samples

  • Indicate presense of heterozygous R206H mutation of the ACVR1 gene 

Etiology/Causes[edit | edit source]

  • Genetic R206H mutation of the ACVR1 gene
  • ACVR1 gene is a bone morphogenetic protein (BMP) type1 receptor signaling endochondral ossification
  • R206H mutation leads to an increase in enhanced BMP signaling
  • Confirmation of a heterozygous gene mutation of the ACVR1 gene

Systemic Involvement[edit | edit source]

Cardiopulmonary system

  • Lungs affected caused by thoracic insufficiencies
  • Restrictive pulmonary diseases


Nervous system

  • Middle ear ossifications
  • Hearing impairments 

Medical Management (current best evidence)[edit | edit source]

Medications 

  • Reduces the pain and severity of flare-ups


Surgical release of joint contractures

  • Usually unsuccessful


Osteotomy of heterotropic bone

  • Mobilizes joints
  • Usually counterproductive because new heterotrophic ossificans can form at the site


Repositioned surgically

  • Improves the patients overall functional status
  • Rare


Ultimately, there is not much that can be done to cure this disease.

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: addfeedhere|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.